ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

DVA DaVita Inc

104.31
2.85 (2.81%)
Dec 01 2023 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 1,219,163
Bid Price
Ask Price
News -
Day High 104.90

Low
70.80

52 Week Range

High
116.97

Day Low 100.56
Share Name Share Symbol Market Stock Type
DaVita Inc DVA NYSE Common Stock
  Price Change Price Change % Share Price Last Trade
2.85 2.81% 104.31 19:00:00
Open Price Low Price High Price Close Price Previous Close
101.49 100.56 104.90 104.31 101.46
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
24,018 1,219,163 US$ 103.62 US$ 126,324,793 - 70.80 - 116.97
Last Trade Type Quantity Price Currency
18:58:17 1 US$ 104.32 USD

DaVita (DVA) Options Flow Summary

Overall Flow

Bearish

Net Premium

-63k

Calls / Puts

100.00%

Buys / Sells

100.00%

OTM / ITM

100.00%

Sweeps Ratio

0.00%

DaVita Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
9.53B 91.30M - 11.61B 560.4M 6.14 17.00
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

DaVita News

Date Time Source News Article
11/30/202309:00PR Newswire (US)DaVita's 'Move It With Purpose' Event Achieves..
11/17/202316:46Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
11/17/202316:45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
11/17/202316:45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
11/17/202316:45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
11/17/202316:45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
11/17/202316:44Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
11/17/202316:44Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
11/17/202316:44Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
11/17/202316:44Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
11/17/202316:44Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
11/08/202305:59IH Market NewsWednesday’s Wall Street Highlights: Spirit AeroSystems,..
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No DVA Message Board. Create One! See More Posts on DVA Message Board See More Message Board Posts

Historical DVA Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week99.56104.9098.26100.131,098,0144.754.77%
1 Month78.27104.9078.052290.201,520,94326.0433.27%
3 Months95.44104.9071.5186.241,383,3468.879.29%
6 Months93.90116.9771.5191.68975,62410.4111.09%
1 Year74.35116.9770.8088.17820,86029.9640.3%
3 Years110.70136.4865.2898.31784,330-6.39-5.77%
5 Years66.74136.4843.4079.681,123,52037.5756.29%

DaVita Description

DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,100 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives approximately 69% of U.S. sales at government ( primarily Medicare) reimbursement rates, with the remaining 31% coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.

Your Recent History

Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 | help@advfn.com